Daprodia Tablets 10 mg (Dapagliflozin Propanediol Hydrate)

Adult dose

For monotherapy and adjunctive therapy in type 2 diabetes, take 10 mg once daily. During initial combination therapy with metformin, take 5 mg or 10 mg once daily. Administration may occur at any time of the day regardless of food intake, and the tablet should be swallowed whole.

Child dose

The efficacy and safety of this medication in children under 18 years have not been established and should not be administered.

This medication should not be used in patients with allergies to the main ingredient or excipients, or in patients with type 1 diabetes or diabetic ketoacidosis. Moreover, patients with lactose intolerance or specific genetic issues and patients undergoing dialysis should not take this medication. Caution is required for patients with reduced fluid volume or renal dysfunction, and blood pressure and kidney function should be closely monitored before and after administration. This medication may have reduced blood sugar control efficacy in patients with severely impaired kidney function. There is a risk of genital and urinary tract infections during treatment, and immediate treatment is necessary if symptoms develop. Due to the risk of hypoglycemia, dosage adjustments may be needed when taken alongside insulin or sulfonylureas. Watch for dehydration or hypotension symptoms due to reduced fluid volume, and temporarily discontinue use if symptoms are severe. There is a risk of diabetic ketoacidosis, so immediate hospital visit is required if symptoms such as vomiting, abdominal pain, or shortness of breath occur. Serious infection symptoms like necrotizing fasciitis are rarely reported, so consult a doctor if there is pain or redness around the genital area. Elderly patients or those with renal dysfunction should use this medication with extra caution, and regular kidney function tests are recommended. Pregnant or breastfeeding women should not take this medication and should discontinue use upon confirmation of pregnancy. There is no specific antidote for overdose; appropriate treatment should be administered according to symptoms. This medication does not significantly affect driving or machinery operation, but caution is needed due to potential hypoglycemia symptoms. Safety and efficacy in children under 18 years have not yet been established, and its use is not recommended. This medication must be stored in its original container and kept out of reach of children.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with fever, blisters, peeling skin, mucous membrane pain in mouth/eyes, shortness of breath or difficulty breathing, asthma attack, respiratory disturbances with cough and fever, yellowing of skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, vision disturbances, paralysis,

Mild side effects

Vulvitis, balanitis and related genital infections, urinary tract infections, hypoglycemia, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, elevated hematocrit, increased serum creatinine, elevated blood urea, weight loss, rash, angioedema, gastrointestinal disorders (gastroesophageal reflux disease, upper abdominal pain, diverticulitis, intestinal perforation, acute pancreatitis, chronic pancreatitis, dyspepsia, nausea, diarrhea, vomiting, etc.),

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is best stored at a cool room temperature between 1 to 30 degrees Celsius.

Appearance

Yellow, convex, diamond-shaped film-coated tablet

Package unit

PTP - 28 tablets per box [28 tablets (7 tablets/PTP x 4)], bottle - 30 tablets per bottle